Milani P, Gagliardi S, Cova E, Cereda C (2011). „SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS”. Neurology Research International2011, 458427. o. DOI:10.1155/2011/458427. PMID21603028. PMC3096450.
Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX (1993. március 1.). „Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis”. Nature362 (6415), 59–62. o. DOI:10.1038/362059a0. PMID8446170.
Trist BG, Hilton JB, Hare DJ, Crouch PJ, Double KL (2021. április 1.). „Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic”. Angewandte Chemie60 (17), 9215–9246. o. DOI:10.1002/anie.202000451. PMID32144830. PMC8247289.
Estácio SG, Leal SS, Cristóvão JS, Faísca PF, Gomes CM (2015. február 1.). „Calcium binding to gatekeeper residues flanking aggregation-prone segments underlies non-fibrillar amyloid traits in superoxide dismutase 1 (SOD1)”. Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics1854 (2), 118–126. o. DOI:10.1016/j.bbapap.2014.11.005. PMID25463043.
Sea K, Sohn SH, Durazo A, Sheng Y, Shaw BF, Cao X, Taylor AB, Whitson LJ, Holloway SP, Hart PJ, Cabelli DE, Gralla EB, Valentine JS (2015. január 1.). „Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase”. The Journal of Biological Chemistry290 (4), 2405–2418. o. DOI:10.1074/jbc.M114.588798. PMID25433341. PMC4303690.
Khare SD, Caplow M, Dokholyan NV (2004. október 1.). „The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis”. Proceedings of the National Academy of Sciences of the United States of America101 (42), 15094–15099. o. DOI:10.1073/pnas.0406650101. PMID15475574. PMC524068.
Murray CJ, Lopez AD (1997. május 1.). „Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study”. Lancet349 (9064), 1498–1504. o. DOI:10.1016/S0140-6736(96)07492-2. PMID9167458.
Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H (2007. augusztus 1.). „Trends in oxidative aging theories”. Free Radical Biology & Medicine43 (4), 477–503. o. DOI:10.1016/j.freeradbiomed.2007.03.034. PMID17640558.
Cabaña-Muñoz ME, Parmigiani-Izquierdo JM, Bravo-González LA, Kyung HM, Merino JJ (2015. június 1.). „Increased Zn/Glutathione Levels and Higher Superoxide Dismutase-1 Activity as Biomarkers of Oxidative Stress in Women with Long-Term Dental Amalgam Fillings: Correlation between Mercury/Aluminium Levels (in Hair) and Antioxidant Systems in Plasma”. PLOS ONE10 (6), e0126339. o. DOI:10.1371/journal.pone.0126339. PMID26076368. PMC4468144.
Al-Chalabi A, Leigh PN (2000. augusztus 1.). „Recent advances in amyotrophic lateral sclerosis”. Current Opinion in Neurology13 (4), 397–405. o. DOI:10.1097/00019052-200008000-00006. PMID10970056.
Redler RL, Dokholyan NV. The complex molecular biology of amyotrophic lateral sclerosis (ALS), Molecular Biology of Neurodegenerative Diseases, Progress in Molecular Biology and Translational Science, 215–62. o.. DOI: 10.1016/B978-0-12-385883-2.00002-3 (2012. január 1.). ISBN 9780123858832
Gagliardi S, Cova E, Davin A, Guareschi S, Abel K, Alvisi E, Laforenza U, Ghidoni R, Cashman JR, Ceroni M, Cereda C (2010. augusztus 1.). „SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis”. Neurobiology of Disease39 (2), 198–203. o. DOI:10.1016/j.nbd.2010.04.008. PMID20399857.
Kikuchi H, Furuta A, Nishioka K, Suzuki SO, Nakabeppu Y, Iwaki T (2002. április 1.). „Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis”. Acta Neuropathologica103 (4), 408–414. o. DOI:10.1007/s00401-001-0480-x. PMID11904761.
Warita H, Hayashi T, Murakami T, Manabe Y, Abe K (2001. április 1.). „Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice”. Brain Research. Molecular Brain Research89 (1–2), 147–152. o. DOI:10.1016/S0169-328X(01)00029-8. PMID11311985.
Rosen DR, Bowling AC, Patterson D, Usdin TB, Sapp P, Mezey E, McKenna-Yasek D, O'Regan J, Rahmani Z, Ferrante RJ (1994. június 1.). „A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis”. Human Molecular Genetics3 (6), 981–987. o. DOI:10.1093/hmg/3.6.981. PMID7951249.
Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, Schoenfeld DA, Hosler BA, Horvitz HR, Brown RH (1997. február 1.). „Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis”. Annals of Neurology41 (2), 210–221. o. DOI:10.1002/ana.410410212. PMID9029070.
Valentine JS, Hart PJ (2003. április 1.). „Misfolded CuZnSOD and amyotrophic lateral sclerosis”. Proceedings of the National Academy of Sciences of the United States of America100 (7), 3617–3622. o. DOI:10.1073/pnas.0730423100. PMID12655070. PMC152971.
Broom WJ, Johnson DV, Auwarter KE, Iafrate AJ, Russ C, Al-Chalabi A, Sapp PC, McKenna-Yasek D, Andersen PM, Brown RH (2008. január 1.). „SOD1A4V-mediated ALS: absence of a closely linked modifier gene and origination in Asia”. Neuroscience Letters430 (3), 241–245. o. DOI:10.1016/j.neulet.2007.11.004. PMID18055113.
Bergemalm D, Jonsson PA, Graffmo KS, Andersen PM, Brännström T, Rehnmark A, Marklund SL (2006. április 1.). „Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models”. The Journal of Neuroscience26 (16), 4147–4154. o. DOI:10.1523/JNEUROSCI.5461-05.2006. PMID16624935. PMC6673995.
Pan L, Yoshii Y, Otomo A, Ogawa H, Iwasaki Y, Shang HF, Hadano S (2012). „Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice”. PLOS ONE7 (3), e33409. o. DOI:10.1371/journal.pone.0033409. PMID22438926. PMC3306410.
Vargas MR, Johnson DA, Johnson JA (2011. szeptember 1.). „Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model”. Neurobiology of Disease43 (3), 543–551. o. DOI:10.1016/j.nbd.2011.04.025. PMID21600285. PMC3139005.
Komatsu T, Duckyoung Y, Ito A, Kurosawa K, Maehata Y, Kubodera T, Ikeda M, Lee MC (2013. szeptember 1.). „Increased oxidative stress biomarkers in the saliva of Down syndrome patients”. Archives of Oral Biology58 (9), 1246–1250. o. DOI:10.1016/j.archoralbio.2013.03.017. PMID23714170.
Pallardó FV, Degan P, d'Ischia M, Kelly FJ, Zatterale A, Calzone R, Castello G, Fernandez-Delgado R, Dunster C, Lloret A, Manini P, Pisanti MA, Vuttariello E, Pagano G (2006. augusztus 1.). „Multiple evidence for an early age pro-oxidant state in Down Syndrome patients”. Biogerontology7 (4), 211–220. o. DOI:10.1007/s10522-006-9002-5. PMID16612664.
Casareno RL, Waggoner D, Gitlin JD (1998. szeptember 1.). „The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase”. The Journal of Biological Chemistry273 (37), 23625–23628. o. DOI:10.1074/jbc.273.37.23625. PMID9726962.
Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, Brown RH (2004. július 1.). „Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria”. Neuron43 (1), 19–30. o. DOI:10.1016/j.neuron.2004.06.021. PMID15233914.
Cova E, Ghiroldi A, Guareschi S, Mazzini G, Gagliardi S, Davin A, Bianchi M, Ceroni M, Cereda C (2010. október 1.). „G93A SOD1 alters cell cycle in a cellular model of Amyotrophic Lateral Sclerosis”. Cellular Signalling22 (10), 1477–1484. o. DOI:10.1016/j.cellsig.2010.05.016. PMID20561900.
Cova E, Cereda C, Galli A, Curti D, Finotti C, Di Poto C, Corato M, Mazzini G, Ceroni M (2006. május 1.). „Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients”. Neuroscience Letters399 (3), 186–190. o. DOI:10.1016/j.neulet.2006.01.057. PMID16495003.
nih.gov
pubmed.ncbi.nlm.nih.gov
Milani P, Gagliardi S, Cova E, Cereda C (2011). „SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS”. Neurology Research International2011, 458427. o. DOI:10.1155/2011/458427. PMID21603028. PMC3096450.
Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX (1993. március 1.). „Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis”. Nature362 (6415), 59–62. o. DOI:10.1038/362059a0. PMID8446170.
Trist BG, Hilton JB, Hare DJ, Crouch PJ, Double KL (2021. április 1.). „Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic”. Angewandte Chemie60 (17), 9215–9246. o. DOI:10.1002/anie.202000451. PMID32144830. PMC8247289.
Estácio SG, Leal SS, Cristóvão JS, Faísca PF, Gomes CM (2015. február 1.). „Calcium binding to gatekeeper residues flanking aggregation-prone segments underlies non-fibrillar amyloid traits in superoxide dismutase 1 (SOD1)”. Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics1854 (2), 118–126. o. DOI:10.1016/j.bbapap.2014.11.005. PMID25463043.
Sea K, Sohn SH, Durazo A, Sheng Y, Shaw BF, Cao X, Taylor AB, Whitson LJ, Holloway SP, Hart PJ, Cabelli DE, Gralla EB, Valentine JS (2015. január 1.). „Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase”. The Journal of Biological Chemistry290 (4), 2405–2418. o. DOI:10.1074/jbc.M114.588798. PMID25433341. PMC4303690.
Khare SD, Caplow M, Dokholyan NV (2004. október 1.). „The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis”. Proceedings of the National Academy of Sciences of the United States of America101 (42), 15094–15099. o. DOI:10.1073/pnas.0406650101. PMID15475574. PMC524068.
Murray CJ, Lopez AD (1997. május 1.). „Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study”. Lancet349 (9064), 1498–1504. o. DOI:10.1016/S0140-6736(96)07492-2. PMID9167458.
Maslov LN, Naryzhnaia NV, Podoksenov I, Prokudina ES, Gorbunov AS, Zhang I, Peĭ Z (2015. január 1.). „Reactive oxygen species are triggers and mediators of an increase in cardiac tolerance to impact of ischemia-reperfusion”. Rossiiskii Fiziologicheskii Zhurnal Imeni I. M. Sechenova101 (1), 3–24. o. PMID25868322.
Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H (2007. augusztus 1.). „Trends in oxidative aging theories”. Free Radical Biology & Medicine43 (4), 477–503. o. DOI:10.1016/j.freeradbiomed.2007.03.034. PMID17640558.
Cabaña-Muñoz ME, Parmigiani-Izquierdo JM, Bravo-González LA, Kyung HM, Merino JJ (2015. június 1.). „Increased Zn/Glutathione Levels and Higher Superoxide Dismutase-1 Activity as Biomarkers of Oxidative Stress in Women with Long-Term Dental Amalgam Fillings: Correlation between Mercury/Aluminium Levels (in Hair) and Antioxidant Systems in Plasma”. PLOS ONE10 (6), e0126339. o. DOI:10.1371/journal.pone.0126339. PMID26076368. PMC4468144.
Al-Chalabi A, Leigh PN (2000. augusztus 1.). „Recent advances in amyotrophic lateral sclerosis”. Current Opinion in Neurology13 (4), 397–405. o. DOI:10.1097/00019052-200008000-00006. PMID10970056.
Gagliardi S, Cova E, Davin A, Guareschi S, Abel K, Alvisi E, Laforenza U, Ghidoni R, Cashman JR, Ceroni M, Cereda C (2010. augusztus 1.). „SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis”. Neurobiology of Disease39 (2), 198–203. o. DOI:10.1016/j.nbd.2010.04.008. PMID20399857.
Kikuchi H, Furuta A, Nishioka K, Suzuki SO, Nakabeppu Y, Iwaki T (2002. április 1.). „Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis”. Acta Neuropathologica103 (4), 408–414. o. DOI:10.1007/s00401-001-0480-x. PMID11904761.
Warita H, Hayashi T, Murakami T, Manabe Y, Abe K (2001. április 1.). „Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice”. Brain Research. Molecular Brain Research89 (1–2), 147–152. o. DOI:10.1016/S0169-328X(01)00029-8. PMID11311985.
Rosen DR, Bowling AC, Patterson D, Usdin TB, Sapp P, Mezey E, McKenna-Yasek D, O'Regan J, Rahmani Z, Ferrante RJ (1994. június 1.). „A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis”. Human Molecular Genetics3 (6), 981–987. o. DOI:10.1093/hmg/3.6.981. PMID7951249.
Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, Schoenfeld DA, Hosler BA, Horvitz HR, Brown RH (1997. február 1.). „Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis”. Annals of Neurology41 (2), 210–221. o. DOI:10.1002/ana.410410212. PMID9029070.
Valentine JS, Hart PJ (2003. április 1.). „Misfolded CuZnSOD and amyotrophic lateral sclerosis”. Proceedings of the National Academy of Sciences of the United States of America100 (7), 3617–3622. o. DOI:10.1073/pnas.0730423100. PMID12655070. PMC152971.
Broom WJ, Johnson DV, Auwarter KE, Iafrate AJ, Russ C, Al-Chalabi A, Sapp PC, McKenna-Yasek D, Andersen PM, Brown RH (2008. január 1.). „SOD1A4V-mediated ALS: absence of a closely linked modifier gene and origination in Asia”. Neuroscience Letters430 (3), 241–245. o. DOI:10.1016/j.neulet.2007.11.004. PMID18055113.
Bergemalm D, Jonsson PA, Graffmo KS, Andersen PM, Brännström T, Rehnmark A, Marklund SL (2006. április 1.). „Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models”. The Journal of Neuroscience26 (16), 4147–4154. o. DOI:10.1523/JNEUROSCI.5461-05.2006. PMID16624935. PMC6673995.
Pan L, Yoshii Y, Otomo A, Ogawa H, Iwasaki Y, Shang HF, Hadano S (2012). „Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice”. PLOS ONE7 (3), e33409. o. DOI:10.1371/journal.pone.0033409. PMID22438926. PMC3306410.
Vargas MR, Johnson DA, Johnson JA (2011. szeptember 1.). „Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model”. Neurobiology of Disease43 (3), 543–551. o. DOI:10.1016/j.nbd.2011.04.025. PMID21600285. PMC3139005.
Komatsu T, Duckyoung Y, Ito A, Kurosawa K, Maehata Y, Kubodera T, Ikeda M, Lee MC (2013. szeptember 1.). „Increased oxidative stress biomarkers in the saliva of Down syndrome patients”. Archives of Oral Biology58 (9), 1246–1250. o. DOI:10.1016/j.archoralbio.2013.03.017. PMID23714170.
Pallardó FV, Degan P, d'Ischia M, Kelly FJ, Zatterale A, Calzone R, Castello G, Fernandez-Delgado R, Dunster C, Lloret A, Manini P, Pisanti MA, Vuttariello E, Pagano G (2006. augusztus 1.). „Multiple evidence for an early age pro-oxidant state in Down Syndrome patients”. Biogerontology7 (4), 211–220. o. DOI:10.1007/s10522-006-9002-5. PMID16612664.
Casareno RL, Waggoner D, Gitlin JD (1998. szeptember 1.). „The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase”. The Journal of Biological Chemistry273 (37), 23625–23628. o. DOI:10.1074/jbc.273.37.23625. PMID9726962.
Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, Brown RH (2004. július 1.). „Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria”. Neuron43 (1), 19–30. o. DOI:10.1016/j.neuron.2004.06.021. PMID15233914.
Cova E, Ghiroldi A, Guareschi S, Mazzini G, Gagliardi S, Davin A, Bianchi M, Ceroni M, Cereda C (2010. október 1.). „G93A SOD1 alters cell cycle in a cellular model of Amyotrophic Lateral Sclerosis”. Cellular Signalling22 (10), 1477–1484. o. DOI:10.1016/j.cellsig.2010.05.016. PMID20561900.
Cova E, Cereda C, Galli A, Curti D, Finotti C, Di Poto C, Corato M, Mazzini G, Ceroni M (2006. május 1.). „Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients”. Neuroscience Letters399 (3), 186–190. o. DOI:10.1016/j.neulet.2006.01.057. PMID16495003.
ncbi.nlm.nih.gov
Milani P, Gagliardi S, Cova E, Cereda C (2011). „SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS”. Neurology Research International2011, 458427. o. DOI:10.1155/2011/458427. PMID21603028. PMC3096450.
Trist BG, Hilton JB, Hare DJ, Crouch PJ, Double KL (2021. április 1.). „Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic”. Angewandte Chemie60 (17), 9215–9246. o. DOI:10.1002/anie.202000451. PMID32144830. PMC8247289.
Sea K, Sohn SH, Durazo A, Sheng Y, Shaw BF, Cao X, Taylor AB, Whitson LJ, Holloway SP, Hart PJ, Cabelli DE, Gralla EB, Valentine JS (2015. január 1.). „Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase”. The Journal of Biological Chemistry290 (4), 2405–2418. o. DOI:10.1074/jbc.M114.588798. PMID25433341. PMC4303690.
Khare SD, Caplow M, Dokholyan NV (2004. október 1.). „The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis”. Proceedings of the National Academy of Sciences of the United States of America101 (42), 15094–15099. o. DOI:10.1073/pnas.0406650101. PMID15475574. PMC524068.
Cabaña-Muñoz ME, Parmigiani-Izquierdo JM, Bravo-González LA, Kyung HM, Merino JJ (2015. június 1.). „Increased Zn/Glutathione Levels and Higher Superoxide Dismutase-1 Activity as Biomarkers of Oxidative Stress in Women with Long-Term Dental Amalgam Fillings: Correlation between Mercury/Aluminium Levels (in Hair) and Antioxidant Systems in Plasma”. PLOS ONE10 (6), e0126339. o. DOI:10.1371/journal.pone.0126339. PMID26076368. PMC4468144.
Valentine JS, Hart PJ (2003. április 1.). „Misfolded CuZnSOD and amyotrophic lateral sclerosis”. Proceedings of the National Academy of Sciences of the United States of America100 (7), 3617–3622. o. DOI:10.1073/pnas.0730423100. PMID12655070. PMC152971.
Bergemalm D, Jonsson PA, Graffmo KS, Andersen PM, Brännström T, Rehnmark A, Marklund SL (2006. április 1.). „Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models”. The Journal of Neuroscience26 (16), 4147–4154. o. DOI:10.1523/JNEUROSCI.5461-05.2006. PMID16624935. PMC6673995.
Pan L, Yoshii Y, Otomo A, Ogawa H, Iwasaki Y, Shang HF, Hadano S (2012). „Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice”. PLOS ONE7 (3), e33409. o. DOI:10.1371/journal.pone.0033409. PMID22438926. PMC3306410.
Vargas MR, Johnson DA, Johnson JA (2011. szeptember 1.). „Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model”. Neurobiology of Disease43 (3), 543–551. o. DOI:10.1016/j.nbd.2011.04.025. PMID21600285. PMC3139005.